Skip to content
2000
Volume 15, Issue 1
  • ISSN: 1871-5249
  • E-ISSN: 1875-6166

Abstract

In last decade, the development of new drugs and drug products for central nervous system (CNS) has remained limited due to incomplete elucidation of pathophysiology of many CNS disorders, complexity of the diseases and the lack of technologies for delivery through the blood-brain barrier (BBB). In this article we will summarize the development of diazenyl derivatives of many biologically active moieties like benzodiazepine, formazan, indole, pyrimidine, thiazole, sulfonamide etc. as diagnostic and therapeutic agents for CNS. The potential of already existing azo compounds as potent CNS agents have also been discussed. This overview will provide the researchers an opportunity for further development of new diazenyl derivatives in CNS area.

Loading

Article metrics loading...

/content/journals/cnsamc/10.2174/1871524915666150209123729
2015-04-01
2025-05-13
Loading full text...

Full text loading...

/content/journals/cnsamc/10.2174/1871524915666150209123729
Loading

  • Article Type:
    Research Article
Keyword(s): CNS activities; diagnostic; diazenyl derivatives
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test